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Abstract
Background: Cycle training intensity for patients with chronic obstructive pulmonary disease
(COPD) is normally based on an incremental cycle test. Such tests are expensive and not readily
available to clinicians. The six-minute walk test (6MWT) has been proposed as an alternative to an
incremental cycle test for this purpose, based on the findings of previous research that the peak
oxygen consumption (VO2peak) for the incremental cycle test and the 6MWT was equivalent in
participants with COPD. A regression equation relating distance walked on the 6MWT and peak
work rate (Wpeak) on the incremental cycle test has been described. The aim of this study is to
measure the physiological responses to constant load cycle exercise performed at an intensity of
60% Wpeak determined from the 6MWT in participants with stable COPD.
Methods/Design: This study is a prospective, repeated measures design. Thirty-five participants
with stable COPD and mild to severe lung disease will be recruited from referrals to pulmonary
rehabilitation. Subjects with co-morbidities limiting exercise performance will be excluded. Two
6MWTs will be performed. The better 6MWT will be used to calculate Wpeak for cycle exercise
from a regression equation. After 30 minutes rest, subjects will perform ten minutes of constant-
load cycle exercise at 60% of the calculated Wpeak. During all exercise, cardiorespiratory and
metabolic data (Cosmed K4b2), dyspnoea and rate of perceived exertion (RPE) will be recorded.
The VO2 measured at the end of cycle exercise will be compared to VO2peak of the 6MWT (VO2bike/
VO2walk). Pearson's correlation coefficient will be calculated for the relationship between VO2bike
and VO2walk. A one-way analysis of variance (ANOVA), with Bonferroni correction, will be
performed to determine whether the ratio of VO2bike/VO2walk is affected by disease severity.
Discussion: This novel study will measure the physiological responses to cycle exercise, in terms
of VO2peak, performed at an intensity determined from the 6MWT in participants with COPD.
Positive findings will enable clinicians to more precisely prescribe cycle training intensity by utilising
a simple, reliable and inexpensive 6MWT, thus providing a better standard of care for patients with
COPD referred to pulmonary rehabilitation.
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Background
Exercise training has been regarded as the cornerstone of
pulmonary rehabilitation for patients with chronic
obstructive pulmonary disease (COPD) [1] and highly
recommended as efficacious treatment in reducing disa-
bility [2]. An appropriate prescription of exercise for
patients with COPD is important in ensuring that an
endurance training program in pulmonary rehabilitation
results in peripheral adaptations, reduced dyspnoea and
fatigue in daily activities, and improved function [1,3-5].
Constant-load submaximal cycle exercise is one of the
most common modes of endurance training in pulmo-
nary rehabilitation [6], and has been shown to result in
peripheral adaptations [4] and increased exercise capacity
[3,4]. In order to prescribe exercise, each patient's exercise
capacity needs to be assessed [7]. A maximal incremental
cycle ergometer test is the recommended assessment pro-
tocol to obtain peak oxygen consumption (VO2peak), and
is regarded to be the gold standard of exercise testing for
patients with COPD [7,8]. The intensity for cycle exercise
training is normally prescribed from a percent of VO2peak
or peak work rate (Wpeak) obtained from an incremental
cycle test [7].
The incremental cycle test is most commonly performed
in a laboratory and requires sophisticated equipment and
well-trained staff [7,8]. However, such testing for the large
number of patients referred to pulmonary rehabilitation
may not be feasible due to cost and lack of resources. The
ability to formulate an appropriate prescription of exer-
cise may be compromised if such an exercise test cannot
be performed.
An alternative test, a six-minute walk test, has been pro-
posed as a basis for exercise prescription [9]. The six-
minute walk test (6MWT) is less costly than the incremen-
tal cycle test because the walking test does not require
sophisticated equipment and technical training [10]. Pre-
vious studies have shown that the 6MWT produced simi-
lar VO2peak as the incremental cycle test in participants
with COPD, validating the capability of the 6MWT to
assess exercise capacity in this population [9,11]. In addi-
tion, the six-minute walk distance (6MWD) is signifi-
cantly correlated with both VO2peak [10,12] and Wpeak on
the incremental cycle test in patients with COPD [9].
From the correlation found between 6MWD and work
rate on the incremental cycle test, Luxton et al (2005) pro-
posed that a cycle training intensity could be calculated
from Wpeak in COPD [9]. It is important to determine
whether this method of calculating cycle training intensity
produces adequate physiological responses (in terms of
VO2peak) that would result in a training effect in patients
with COPD. There have been no reports of cycle training
exercise prescription from the 6MWT.
An intensity that exceeds 50% VO2peak is regarded as suffi-
cient to elicit training effects in subjects with COPD [13],
however, an upper limit of % VO2peak for cycle training
intensity has not been reported [6]. In terms of peak work
rate, the recommended training intensity range is from
50% to 80% of Wpeak in COPD [3].
The aim of this study is to measure the physiological
responses to cycle exercise performed at an intensity deter-
mined from the 6MWT in participants with COPD. It is
hypothesised that cycle exercise at 60% Wpeak, calculated
from the results of the 6MWT, will produce a VO2 above
50% VO2peak when compared with peak VO2 from the
6MWT.
Method/Design
Participants
Participants with diagnosed stable COPD, as defined by
the COPDX Guidelines [14], will be recruited for this
study through advertisement or personal contact with
patients referred to the pulmonary rehabilitation unit at
Royal Prince Alfred Hospital, Sydney, Australia. Partici-
pants with mild to severe lung disease will be included.
Mild lung disease is characterised by forced expiratory vol-
ume in one second (FEV1) of 60 to 80% predicted, mod-
erate by FEV1 of 40% to 59% predicted and severe by FEV1
of less than 40% predicted [14]. The study has been
approved by the Human Research Ethics Committees of
The University of Sydney and Royal Prince Alfred Hospi-
tal. Prior to testing, written, informed consent will be
obtained from all participants.
Participants will be excluded if they present with a fever or
increased sputum; a hospital admission in the previous
month; are unable to wear a facemask due to claustropho-
bia or are on long term oxygen therapy. Participants with
cardiovascular, neurological and musculoskeletal co-mor-
bidities that may limit exercise performance will also be
excluded [11,12].
Sample size calculation
Thirty-five participants will be required based on a calcu-
lation of a 95% confidence interval of 0.65 – 0.95 for the
predicted relationship of VO2peak between the 6MWT and
the incremental cycle test to achieve a power of 0.80. We
will enrol 39 participants to allow for 10% drop-out.
Procedures
This study will use a prospective, repeated measures
design (Figure 1). All participants will perform two
6MWTs and a ten-minute constant-load cycle exercise in
that order. The 6MWT will be performed prior to the cycle
exercise as the results of the 6MWT will be required to cal-
culate the intensity of cycle exercise. Participants will be
requested to avoid having caffeinated drinks, a heavyBMC Pulmonary Medicine 2007, 7:9 http://www.biomedcentral.com/1471-2466/7/9
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meal or exercising for at least two hours before the tests
[7,8]. All testing will be performed on one occasion. A
minimum of thirty minutes' rest will be given between the
two walking tests and again before the cycle exercise, in
order to allow for physiological parameters to return to
baseline levels. Spirometry (Niche EasyOne hand-held
spirometer, Device Medical Technologies, Zurich, Switzer-
land), including measures of FEV1; FEV1 percent predicted
(FEV1 %pred); forced vital capacity (FVC); and FVC per-
cent predicted (FVC %pred), will be performed prior to
the walking and cycling tests [15]. Participants will be
asked to take their prescribed bronchodilators prior to
testing.
The 6MWTs will be performed on a 32-metre continuous
rectangular track with standardised instructions and
encouragement given at every minute [10,12]. A second
6MWT will be performed by all participants to account for
a learning effect [10,16]. The longer 6MWD will be
entered into a regression equation determined from a pre-
vious study [9 and personal communication] to calculate
predicted peak watts on a cycle ergometer. Subsequently,
60% of the predicted peak work rate will be prescribed for
the constant-load cycle exercise [4]. In this study, 60%
Wpeak has been chosen from the recommended range of
50% to 80% because it has been shown that this training
intensity is achievable and produced physiological train-
ing adaptations for patients with moderate to severe
COPD [4].
The cycle exercise will be performed on an electronically
braked cycle ergometer (Ergomed EM 840, Siemens Med-
ical Engineering Group, Erlangen, Germany). Participants
will pedal between 50–60 rpm throughout the exercise
[7]. The intensity will be steadily ramped from unloaded
to the designated load over two minutes, according to the
American Thoracic Society and American College of Chest
Physicians guidelines [7]. Subsequently, participants will
pedal at a constant load for a further ten minutes. This
duration of exercise was selected because it is sufficient to
attain steady-state responses [17] and it is similar to an
initial training session as patients with COPD are usually
unable to exercise continuously for more than ten min-
utes at the start of pulmonary rehabilitation [17]. The test
will be terminated if the participants suffer severe dysp-
noea or fatigue or if oxygen saturation (SpO2) falls below
85%.
Measurements
Breath-by-breath values for oxygen consumption (VO2),
carbon dioxide production (VCO2), minute ventilation
(VE), tidal volume (VT), frequency of breathing (fb) and
respiratory quotient (R) will be measured during each test
using a portable metabolic system (Cosmed K4b2, Rome,
Italy). The participants will wear a small battery pack and
portable gas analyser, weighing less than a kilogram, on
their chests and will breathe through a flexible rubber
facemask with the flowmeter attached to the system [18].
Heart rate (HR) and SpO2 will be measured using a porta-
ble heart rate monitor (Polar ®, Polar Electro, Oy, Finland)
and an adult articulated finger clip sensor (Model
8000AA, Nonin Medical Inc, Minnesota, USA), respec-
tively. Data are either transmitted to a Windows-based
computer by telemetry using the Cosmed patented soft-
ware, or stored in its memory unit. The portable metabolic
system has been previously utilised to measure responses
during 6MWT in patients with COPD [9,18,19].
All physiological values will be averaged for the last
twenty seconds of each completed minute and twenty sec-
onds prior to the end of each exercise test. The modified
Borg Category Ratio 0–10 scale will be used to measure
dyspnoea and rate of perceived exertion (RPE) at the
beginning, and during each minute of cycle exercise or at
the third minute of 6MWT, at the end of each test, and
also after a minute of recovery [20].
Research design Figure 1
Research design.
Assessed for eligibility
Exclusion
criteria
6MWT 1 
6MWT 2 
Best distance used in
calculation of peak work
Ten-minute constant load
cycle exercise at 60% of
calculated peak work rate
VO2 analysed
VO2 of the better
6MWT analysedBMC Pulmonary Medicine 2007, 7:9 http://www.biomedcentral.com/1471-2466/7/9
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Maximal voluntary ventilation (MVV) will be calculated
from the equation, FEV1 × 35.5 [21]. VE at the end of the
constant-load cycle exercise will be compared to MVV, i.e.
the ratio VE/MVV is expressed as a percentage to represent
ventilatory reserve of each participant [7].
Based on earlier findings that peak VO2 on the 6MWT and
the incremental cycle test were not significantly different
[9,11], we will assume that each participant's peak VO2 on
the 6MWT (VO2walk) will be equivalent to their VO2peak on
an incremental cycle test. In order to determine the exer-
cise intensity during constant-load cycle exercise, the VO2
measured from the cycle exercise (VO2bike) will be calcu-
lated as a percentage of VO2walk, i.e. VO2bike/VO2walk (%).
In our study, VO2bike will represent the values of VO2 aver-
aged for the last 20 seconds of the final three minutes of
the cycle exercise. VO2walk will represent the peak VO2 on
the 6MWT calculated from the mean of the last 20 seconds
of the final minute.
Statistical methods
Results will be expressed in mean ± standard deviation
(SD). Pearson correlation coefficients will be calculated
for the relationship between VO2bike and VO2walk.
Correlation coefficients will also be calculated for the rela-
tionships between VO2bike/VO2walk  and the following
parameters: a) body mass index; b) measures of lung func-
tion (FEV1, FEV1%pred, FVC, FEV1/FVC ratio); c) 6MWD;
d) percentage of predicted 6MWD; e) dyspnoea; and f)
RPE scores. These parameters will be investigated to deter-
mine their influence on the VO2 response to the pre-
scribed cycle exercise intensity. A one-way analysis of
variance (ANOVA) with a confidence interval (CI) of 0.95
will be performed in a post-hoc analysis with Bonferroni
corrections to determine the effect of disease severity
(mild, moderate and severe) on VO2bike/VO2walk, dysp-
noea and RPE during cycle exercise. The level of signifi-
cance will be set at p < 0.05.
Statistical analyses will be performed on SPSS-Windows
(release 14: SPSS: Chicago, Illinois, USA).
Discussion
The significance of the study pertains to the ability of cli-
nicians to prescribe an appropriate level of cycle exercise
for patients with COPD referred to pulmonary rehabilita-
tion. If the intensity of cycle training at 60% Wpeak, calcu-
lated from the results of the 6MWT, produces a VO2 above
50% VO2peak when compared with peak VO2 from the
6MWT, this simple and inexpensive method of cycle exer-
cise prescription could be adopted by pulmonary rehabil-
itation centers or community health services in both
metropolitan and rural settings. This study will also dem-
onstrate if the exercise intensity prescribed is achievable
by patients with varying levels of disease severity. If the
study findings show that the prescribed intensity is too
high or too low for participants with certain levels of dis-
ease severity, a titration of this intensity and/or a revision
of the prediction equation may be needed. Although we
recognise that it is difficult to define optimal training
intensity, this study may bring clinicians closer to the def-
inition by demonstrating the response, in terms of
%VO2peak, which an exercise intensity of 60% Wpeak elicits.
Similarly, patients with COPD referred to pulmonary
rehabilitation will benefit from an individualised cycle
training program that should be more effective in produc-
ing training outcomes, thus enhancing the standard of
care. To our knowledge, the proposed research is the first
study internationally that will provide a quantitative
method for more precise, individualised prescription of
cycle training intensity from a simple and inexpensive
6MWT in patients with COPD.
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